Implican
PrivateLast Round
Seed
Jan 10, 2023
Total Funding Raised
$1.07M
Company Overview
Implican operates in Healthcare & Life Sciences and is based in Groningen. Its latest recorded funding round was a Seed round in January 2023.
Implican is a medical device company that develops anastomotic devices designed to reduce anastomotic leakage in colorectal surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Implican Comparables
Compare Implican with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CarpoNovum AB | 87% | |
| Seger Surgical Solutions | 81% | |
| Johnson & Johnson | 76% |
For institutional investors. Book with your work email.
Implican Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Implican Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nextgen Ventures | Seed |
| Noordelijke Ontwikkelings Maatschappij | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 49% MoM.
- Jan 1, 2026
Monthly visitors increased 335% MoM.
For institutional investors. Book with your work email.
Implican Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Implican's valuation, stock price, and market status.
Is Implican a public or private company?
Implican is a private company.
What is the current stock price of Implican?
Implican is a private company, so its shares have no public market price. Caplight tracks Implican's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Implican worth (valuation)?
Valuation information for Implican is not publicly available.
Can I buy Implican stock?
Implican shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Implican's last funding round?
Implican's most recent funding round was Seed on January 10, 2023.
Who are the main investors in Implican?
Key investors in Implican include Nextgen Ventures, Noordelijke Ontwikkelings Maatschappij.
Will Implican IPO soon?
No public IPO plans have been announced for Implican.
How can I track Implican secondary market activity?
Caplight tracks bids, offers, and trades in Implican's shares on secondary markets.